Greenleaf Trust’s Omnicell OMCL Stock Holding History

Greenleaf Trust’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,195	Closed	-$235K	–	778
2023 Q2	$235K	Buy	+3,195	New	+$215K	﹤0.01%	675

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Greenleaf Trust's OMCL Position: Q3 2023 in Review

Greenleaf Trust sold out of Omnicell (OMCL) in Q3 2023, closing a stake of 3,195 shares — an estimated $235K sold.

Greenleaf Trust first reported a position in OMCL in Q2 2023 and held it in 1 quarter. The position peaked at $235K in Q2 2023. 312 funds tracked by Wall St. Rank hold OMCL as of Q3 2023.

Greenleaf Trust reported no remaining Omnicell position as of Q3 2023 after selling out during the quarter.
Greenleaf Trust sold 3,195 Omnicell shares in Q3 2023, an estimated $235K.
Greenleaf Trust first reported a position in Omnicell in Q2 2023 and held it in 1 quarter.
Greenleaf Trust's Omnicell position peaked at $235K in Q2 2023.
312 funds tracked by Wall St. Rank held Omnicell as of Q3 2023.

Based on Greenleaf Trust's 13F filing for Q3 2023, filed 9 Nov 2023.